Retinitis Pigmentosa and Netra Restoration Therapy

Retinitis Pigmentosa is a group of inherited retinal dystrophies that cause gradual breakdown of photoreceptors in the retina. It usually affects rods first, leading to night vision difficulty and peripheral vision loss, and may later affect cones and central vision.

RP is best understood as a group of related inherited retinal diseases. Many genes and inheritance patterns can cause an RP-like pattern. This is why symptoms, age of onset, and progression rate vary widely.

Common early symptoms include poor night vision, delayed dark adaptation, difficulty navigating dim environments, and loss of peripheral vision. Some patients also experience glare sensitivity, contrast problems, or difficulty seeing in low light.

Genetics often initiates RP, but downstream mechanisms such as oxidative stress, mitochondrial dysfunction, inflammation, retinal blood flow changes, metabolic stress, neurotrophin signaling, and RPE stress may influence retinal resilience. NRT focuses on supporting this biological terrain.

No. NRT should not be described as a cure for Retinitis Pigmentosa. It is an integrative, adjunctive approach designed to support retinal health, visual function, and the biological environment that influences surviving retinal cells.

No. NRT does not reverse genetic mutations. Its purpose is to support cellular resilience, ocular circulation, mitochondrial function, inflammatory balance, oxidative stress regulation, and whole-body factors that may influence retinal health.

Studies and reviews have reported reduced retinal and choroidal blood flow in RP. Healthy retinal circulation supports oxygen delivery, nutrient exchange, and waste clearance. NRT considers microvascular support an important part of retinal terrain care.

Oxidative stress may contribute to secondary cone degeneration, RPE stress, mitochondrial injury, inflammation, and lipid peroxidation. The retina is especially vulnerable because it has high oxygen demand and lipid-rich photoreceptor membranes.

Mitochondria produce energy needed by photoreceptors and RPE cells. In RP, mitochondrial dysfunction may reduce retinal resilience and increase oxidative stress. NRT therefore includes mitochondrial support as a key biological target.

BDNF and NGF are neurotrophic factors involved in neural survival and repair. They do not explain all of RP, but they are relevant to retinal neuroprotection and cellular resilience. NRT includes neurotrophic support as part of its systems-based model.

The gut-retina axis is an emerging research area. Early studies suggest that gut microbiome changes may be associated with retinal degeneration models, including RP. This does not prove that gut dysfunction causes RP, but it supports considering systemic inflammation, digestion, nutrient absorption, and immune-metabolic terrain.

Some botanical compounds are being studied for antioxidant, anti-inflammatory, vascular, mitochondrial, and neuroprotective effects. Evidence varies, and herbal medicine should be individualized and professionally supervised. NRT interprets herbal medicine through modern systems biology and network pharmacology rather than as a single-target intervention.

Acupuncture and electrical stimulation approaches have been explored in RP-related research, including protocols and small clinical studies focused on visual function or ocular blood flow. Evidence remains limited and should not be overstated. Within NRT, acupuncture is positioned as supportive care rather than a proven cure.

Yes. Regular eye examinations, retinal imaging, visual field testing, and functional assessment remain important. NRT is complementary and should not delay appropriate evaluation, monitoring, or urgent care when symptoms change.

New flashes, sudden floaters, a curtain-like shadow, sudden central blur, sudden distortion, eye pain, or rapid decline in vision should be evaluated promptly by an eye-care professional.